CVE-2023-2139 — MEDIUM (5.4)

Q: What is CVE-2023-2139?

CVE-2023-2139 is a vulnerability with a CVSS score of 5.4 (MEDIUM). A reflected Cross-site Scripting (XSS) Vulnerability in DELMIA Apriso Release 2017 through Release 2022 allows an attacker to execute arbitrary script code.

Q: How severe is CVE-2023-2139?

CVE-2023-2139 has been rated MEDIUM with a CVSS base score of 5.4/10. Review the CVSS metrics above for detailed severity breakdown.

Q: Is there a patch for CVE-2023-2139?

Check the references section above for vendor advisories and patch information. Affected products include: 3Ds Delmia Apriso.

Vulnerability Description

A reflected Cross-site Scripting (XSS) Vulnerability in DELMIA Apriso Release 2017 through Release 2022 allows an attacker to execute arbitrary script code.

CVSS Score

5.4

MEDIUM

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:N

Attack Vector

NETWORK

Attack Complexity

LOW

Privileges Required

NONE

User Interaction

REQUIRED

Scope

UNCHANGED

Confidentiality

LOW

Integrity

LOW

Availability

NONE

Affected Products

Vendor	Product	Versions
3Ds	Delmia Apriso	>= release_2017, <= release_2022

Related Weaknesses (CWE)

CWE-79

References

https://www.3ds.com/vulnerability/advisoriesVendor Advisory
https://www.3ds.com/vulnerability/advisoriesVendor Advisory

FAQ

What is CVE-2023-2139?

CVE-2023-2139 is a vulnerability with a CVSS score of 5.4 (MEDIUM). A reflected Cross-site Scripting (XSS) Vulnerability in DELMIA Apriso Release 2017 through Release 2022 allows an attacker to execute arbitrary script code.

How severe is CVE-2023-2139?

CVE-2023-2139 has been rated MEDIUM with a CVSS base score of 5.4/10. Review the CVSS metrics above for detailed severity breakdown.

Is there a patch for CVE-2023-2139?

Check the references section above for vendor advisories and patch information. Affected products include: 3Ds Delmia Apriso.